GET3 regulates apoptosis via tail-anchoring of MCL1

Chun Yin Yu1, Mingxuan Du1, Tsz Kwan Yeung1

  • 1Division of Life Science, The Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.

Insights

The GET pathway regulates apoptosis by controlling MCL1, a key protein. GET3 depletion impacts cell cycle and survival, highlighting MCL1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The BCL2-like protein MCL1 is crucial for apoptosis and other cellular functions.
  • Many BCL2 family proteins are tail-anchored (TA) proteins, but MCL1's membrane targeting mechanism is unclear.
  • The Guided Entry (GET) pathway is a primary route for TA protein membrane insertion.

Purpose of the Study:

  • To investigate the role of the GET pathway, specifically GET3 (ASNA1/TRC40), in regulating MCL1 and apoptosis.
  • To determine if MCL1 is a tail-anchored cargo of the GET pathway.
  • To elucidate the functional consequences of GET3 deficiency on cell cycle, apoptosis, and survival.

Main Methods:

  • Utilized degron-mediated depletion of GET3 in human cell lines (HeLa and RPE1).
  • Assessed cell cycle progression, apoptosis markers, and clonogenic survival.
  • Performed co-immunoprecipitation to detect interactions between GET3 and MCL1.
  • Investigated MCL1 expression levels under GET3 depletion and overexpression conditions.

Main Results:

  • GET3 depletion caused cell cycle arrest in HeLa and RPE1 cells.
  • GET3 deficiency led to increased apoptosis and reduced survival, particularly in HeLa cells.
  • MCL1 expression decreased with GET3 depletion and increased with GET3 overexpression, indicating MCL1 is a GET3 cargo.
  • Direct interaction between GET3 and MCL1's C-terminal tail was confirmed.
  • GET3 depletion exacerbated apoptosis induced by MCL1 inhibitors and prolonged mitotic arrest.

Conclusions:

  • The GET pathway, via GET3, plays a significant role in regulating apoptosis.
  • MCL1 is a tail-anchored protein targeted by the GET pathway.
  • GET3 deficiency sensitizes cells to apoptosis, especially under stress conditions involving MCL1 inhibition or mitotic arrest.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Tail-anchoring of Proteins in the ER Membrane01:45

Tail-anchoring of Proteins in the ER Membrane

Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...